181 related articles for article (PubMed ID: 15094711)
61. Cyclooxygenase-2 expression and cell proliferation are increased in MUC2-positive area of columnar-lined esophagus.
Jang TJ; Cho MY
Pathol Int; 2005 Sep; 55(9):546-9. PubMed ID: 16143029
[TBL] [Abstract][Full Text] [Related]
62. Definition of Barrett's oesophagus.
Van Eyken P
Acta Gastroenterol Belg; 2000; 63(1):10-2. PubMed ID: 10907312
[TBL] [Abstract][Full Text] [Related]
63. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
[TBL] [Abstract][Full Text] [Related]
64. Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.
Levine DS; Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1989 Feb; 96(2 Pt 1):355-67. PubMed ID: 2910757
[TBL] [Abstract][Full Text] [Related]
65. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus.
Haggitt RC; Tryzelaar J; Ellis FH; Colcher H
Am J Clin Pathol; 1978 Jul; 70(1):1-5. PubMed ID: 696666
[TBL] [Abstract][Full Text] [Related]
66. Review on novel concepts of columnar lined esophagus.
Lenglinger J; See SF; Beller L; Cosentini EP; Asari R; Wrba F; Riegler M; Schoppmann SF
Wien Klin Wochenschr; 2013 Oct; 125(19-20):577-90. PubMed ID: 24061694
[TBL] [Abstract][Full Text] [Related]
67. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
[TBL] [Abstract][Full Text] [Related]
68. Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.
Fabian T; Leung A
Surg Clin North Am; 2021 Jun; 101(3):381-389. PubMed ID: 34048759
[TBL] [Abstract][Full Text] [Related]
69. Serial Endoscopic Evaluation of Esophageal Disease in a Cancer Model: A Paradigm Shift for Esophageal Adenocarcinoma (EAC) Drug Discovery and Development.
Omstead AN; Kosovec JE; Matsui D; Martin SA; Smith MA; Aaron Guel D; Kolano J; Komatsu Y; Habib F; Lai C; Christopher K; Kelly RJ; Zaidi AH; Jobe BA
Cancer Invest; 2018; 36(7):363-370. PubMed ID: 30142016
[TBL] [Abstract][Full Text] [Related]
70. Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenocarcinoma.
Chandrasoma P; Wijetunge S; DeMeester S; Ma Y; Hagen J; Zamis L; DeMeester T
Am J Surg Pathol; 2012 Jan; 36(1):1-7. PubMed ID: 21959311
[TBL] [Abstract][Full Text] [Related]
71. Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
Groisman GM; Amar M; Meir A
Mod Pathol; 2004 Oct; 17(10):1282-8. PubMed ID: 15167938
[TBL] [Abstract][Full Text] [Related]
72. Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia.
Wang DH; Tiwari A; Kim ME; Clemons NJ; Regmi NL; Hodges WA; Berman DM; Montgomery EA; Watkins DN; Zhang X; Zhang Q; Jie C; Spechler SJ; Souza RF
J Clin Invest; 2014 Sep; 124(9):3767-80. PubMed ID: 25083987
[TBL] [Abstract][Full Text] [Related]
73. Natural history of Barrett's esophagus.
Milind R; Attwood SE
World J Gastroenterol; 2012 Jul; 18(27):3483-91. PubMed ID: 22826612
[TBL] [Abstract][Full Text] [Related]
74. Barrett's disease: pathophysiology of metaplasia and adenocarcinoma.
Pera M; Trastek VF; Pairolero PC; Cardesa A; Allen MS; Deschamps C
Ann Thorac Surg; 1993 Nov; 56(5):1191-7. PubMed ID: 8239829
[TBL] [Abstract][Full Text] [Related]
75. Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort.
Gall A; Fero J; McCoy C; Claywell BC; Sanchez CA; Blount PL; Li X; Vaughan TL; Matsen FA; Reid BJ; Salama NR
PLoS One; 2015; 10(6):e0129055. PubMed ID: 26076489
[TBL] [Abstract][Full Text] [Related]
76. Mucin histochemistry of intestinal metaplasia in Barrett's esophagus.
Jauregui HO; Davessar K; Hale JH; Kessimian N; Cenoz C
Mod Pathol; 1988 May; 1(3):188-92. PubMed ID: 3237699
[TBL] [Abstract][Full Text] [Related]
77. Transcommitment: Paving the Way to Barrett's Metaplasia.
Wang DH; Souza RF
Adv Exp Med Biol; 2016; 908():183-212. PubMed ID: 27573773
[TBL] [Abstract][Full Text] [Related]
78. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract][Full Text] [Related]
79. Glycoconjugate expression in normal, metaplastic, and neoplastic human upper gastrointestinal mucosa.
Shimamoto C; Weinstein WM; Boland CR
J Clin Invest; 1987 Dec; 80(6):1670-8. PubMed ID: 3680520
[TBL] [Abstract][Full Text] [Related]
80. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
